Jiangsu Wanhai is a Chinese healthcare company with more than 15 years of innovation in diabetes care and its main business is to develop and supply various kinds of disposable and reusable insulin pen, plastic insulin pen and HGH disposable pen for pharmaceutical and biotechnology companies that develop, manufacture and market medications for self-injection. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: diabetes, growth disorders and obesity. Jiangsu Wanhai has its own Independent Intellectual Property Rights and can apply intellectual patent protection in many countries. Jiangsu Wanhai ensures that all device solutions are provided with solid intellectual property protection and do not infringe third party patents.
